Latest news with #MaxLin
Hans India
27-07-2025
- Business
- Hans India
Taiwanese team explores investment avenues in Sri City
Sri City: A14-member Taiwanese business delegation, led by Max Lin, executive director of Pou Chen Group – the world's largest manufacturer of branded athletic and casual footwear, visited Sri City on Saturday to explore investment opportunities. The visit marked a key step in strengthening economic ties between Taiwan and India, particularly in the non-leather footwear manufacturing sector. The delegation, comprising Tier 2 and Tier 3 suppliers to Pou Chen Group, was received by Kuppam Area Development Authority (KADA) project director Vikas Marmat and senior vice-president (Marketing) R Shivasankar. During his presentation, Shivasankar highighted existing Taiwanese investments such as Rechi Precision Co. Ltd., a joint venture with Daikin. Industries and commerce secretary of AP Dr N Yuvaraj participated virtually, while officials from the Andhra Pradesh Economic Development Board (APEDB) and Invest India engaged in discussions with the delegates. Conversations focused on ease of doing business, connectivity, and policy support, especially in the Sri City–Kuppam industrial corridor. With a specific focus on the non-leather footwear sector, the delegates expressed keen interest in the state's progressive industrial policies and Sri City's well-planned infrastructure. Max Lin praised the state's industrial vision, stating, 'We are delighted to visit Andhra Pradesh and impressed with the comprehensive and thoughtful plan transforming this amazing place.'
Yahoo
11-07-2025
- Business
- Yahoo
Henry Schein (HSIC) Announces Completion of $250 Million Investment by KKR
Henry Schein, Inc. (NASDAQ:HSIC) is one of the The company announced the completion of a $250 million strategic investment by funds affiliated with KKR, which is a leading global investment firm. Furthermore, William K. 'Dan' Daniel has officially joined Henry Schein, Inc. (NASDAQ:HSIC)'s Board of Directors as an independent director. He joined Max Lin, who became a member of the company's Board on May 2, 2025. As per Henry Schein, Inc. (NASDAQ:HSIC)'s Chief Executive Officer, deep experience of these appointments in health care, operations, and strategic growth is expected to be invaluable, with the company executing on its BOLD+1 strategy and creating long-term value. A close-up of a patient's mouth, the dental products from the company in view. Henry Schein, Inc. (NASDAQ:HSIC) continues to advance its BOLD+1 Strategic Plan, which was refreshed for 2025 to 2027, with the team focused towards growing distribution business via enhanced operational efficiency and improved customer experience, growing the dental and medical specialty businesses and corporate brand products as well as further developing the digital footprint and digital solutions. The company remains committed to its long-term financial goal of high single-digit to low double-digit earnings growth through successfully executing against the strategy. While we acknowledge the potential of HSIC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
16-05-2025
- Business
- Yahoo
Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors
MELVILLE, N.Y., May 16, 2025--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. "Dan" Daniel, Executive Advisor to KKR and former Executive Vice President of Danaher Corporation, has officially joined Henry Schein's Board of Directors as an independent director. He joins Max Lin, Partner at KKR and leader of the firm's Health Care industry team in the Americas, who became a member of Henry Schein's Board of Directors on May 2, 2025. Max Lin leads the Health Care industry team within KKR, and since joining in 2005, he has overseen a number of investments in the areas of dental services and other health care providers, medical products and equipment, and health care software and information technology. Dan Daniel has over three decades of global leadership experience in industrial and health care sectors, including 14 years as Executive Vice President at Danaher, where he oversaw multiple segments and played a key role in advancing the company's culture and business system. In connection with each of their appointments, Mr. Lin was appointed to the Nominating and Governance Committee as Vice Chair; Mr. Daniel was appointed to the Compensation Committee; and each of Mr. Lin and Mr. Daniel was appointed to the Strategic Advisory Committee. "We are pleased to welcome Max and Dan to the Board as we embark on this exciting next chapter for Henry Schein," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "Their deep experience in health care, operations, and strategic growth will be invaluable as we continue executing on our BOLD+1 strategy and creating long-term value for our stakeholders." About Henry Schein, Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at and @HenrySchein on X. About KKRKKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR's insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR's investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR's website at For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group's website at View source version on Contacts InvestorsRonald N. SouthSenior Vice President and Chief Financial (631) 843-5500Graham StanleyVice President, Investor Relations and Strategic Financial Project (631) 843-5500MediaHenry Schein Tim VassilakosExecutive Director, Global Corporate (516) 510-0926KKR Liidia Liuksilamedia@
